Article Information
History
- October 24, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xiaofen Zheng1 (autumnforever1111{at}163.com),
- Bingbing Xie2,
- Yan Liu3,
- Ming Zhu3,
- Shu Zhang3,
- Chengjun Ban4,
- Jing Geng5,
- Dingyuan Jiang2,
- Yanhong Ren2,
- Huaping Dai2,6 (daihuaping{at}ccmu.edu.cn) and
- Chen Wang2
- 1 Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing , China;2.The Second Affiliated Hospital of Zhejiang Chinese Medical University,, Hangzhou, China;
- 2 Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking;
- 3 Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing , China;
- 4 Department of Respiration of Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China;
- 5 Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peki
- ↵* Corresponding author; email: daihuaping{at}ccmu.edu.cn
Posted October 24, 2019.
Direct medical costs of hospitalized patients with idiopathic pulmonary fibrosis in China
